# Effect of Cobicistat Versus Ritonavir Boosting on the Brain Permeation of Darunavir in HIV-infected Individuals

> **NCT02503462** · PHASE4 · TERMINATED · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 7 (actual)

## Conditions studied

- AIDS-related Dementia Complex

## Interventions

- **DRUG:** Darunavir
- **DRUG:** ritonavir
- **DRUG:** cobicistat

## Key facts

- **NCT ID:** NCT02503462
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-07
- **Primary completion:** 2017-01
- **Final completion:** 2017-01
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** No additional patients fulfilling the inclusion criteria
- **Last updated:** 2017-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02503462

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02503462, "Effect of Cobicistat Versus Ritonavir Boosting on the Brain Permeation of Darunavir in HIV-infected Individuals". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02503462. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*